Nonspecific ulcerative colitis as a sequel to amebic dysentery.
In two patients, treatment of amebic dysentery was followed (despite the disappearance of the infecting organism) by an illness with the clinical, pathological, and radiological characteristics of nonspecific ulcerative colitis. Their case histories indicate that in addition to persistent or recurrent amebic infection, the irritable colon syndrome, and ulcerative postdysenteric colitis, nonspecific ulcerative colitis should be kept in mind in the evaluation and therapy of continuing symptoms in patients with treated amebic dysentery.
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery; D004205:Cromolyn Sodium / Q000627:therapeutic use; D004404:Dysentery, Amebic / Q000150:complications* / Q000188:drug therapy; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007081:Ileostomy; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D013577:Syndrome
D000890:Anti-Infective Agents; D000981:Antiprotozoal Agents; D011239:Prednisolone; D004205:Cromolyn Sodium; D006854:Hydrocortisone